CHU Dijon, Department of Oral and Maxillofacial Surgery, Department of Plastic Reconstructive and Hand Surgery - Centre Hospitalier Universitaire, Boulevard de Lattre-de-Tassigny, 21000 Dijon, France; University of Bourgogne Franche-Comté, Lipids Nutrition Cancer Team NuTox, UMR866, Boulevard Jeanne d'Arc, 21000 Dijon, France.
CHU Dijon, Department of Oral and Maxillofacial Surgery, Department of Plastic Reconstructive and Hand Surgery - Centre Hospitalier Universitaire, Boulevard de Lattre-de-Tassigny, 21000 Dijon, France.
J Stomatol Oral Maxillofac Surg. 2017 Jun;118(3):143-146. doi: 10.1016/j.jormas.2017.04.001. Epub 2017 Apr 8.
Malignant intraosseous odontogenic tumors (MIOT) of the jaws are very rare. The diagnosis is difficult. Clinical, paraclinical and histological diagnostic criteria, strict are well established. But the International Union Against Cancer (UICC) does not provide TNM classification that will allow harmonization of the treatment. Indeed, despite their location, they cannot be classified as primary tumors of the oral cavity because of their localization in the bone marrow, making them systematically classified as T4. We propose a classification taking into account the clinical and radiological data.
颌骨恶性骨内牙源性肿瘤(MIOT)非常罕见。诊断困难。临床、影像和组织学诊断标准已经得到很好的确立。但国际癌症联盟(UICC)没有提供 TNM 分类,这将无法实现治疗的协调。事实上,尽管它们位于颌骨,由于它们位于骨髓内,不能被归类为口腔原发性肿瘤,而被系统地归类为 T4。我们提出了一种分类方法,考虑到了临床和影像学数据。